What is the Verdict? A Systematic Review of Dupilumab and Lichen Planus
- PMID: 40579712
- DOI: 10.1111/ijd.17909
What is the Verdict? A Systematic Review of Dupilumab and Lichen Planus
Keywords: PD‐1 inhibitor; drug‐induced lichen planus; dupilumab; immunotherapy; lichen planus; lichen planus pemphigoides; lichenoid drug eruption.
References
-
- K. Boch, E. A. Langan, K. Kridin, D. Zillikens, R. J. Ludwig, and K. Bieber, “Lichen Planus,” Frontiers in Medicine 8 (2021): 737813.
-
- S. Kazemi, M. Murphrey, and J. E. Hawkes, “Rapid Resolution of Widespread Cutaneous Lichen Planus and Generalized Pruritus in an Elderly Patient Following Treatment With Dupilumab,” JAAD Case Reports 30 (2022): 108–110.
-
- S. Z. Li, Y. H. Xie, S. H. Wang, R. Y. Fang, H. Z. Jin, and Y. G. Zuo, “Case Report: Successful Treatment of Non‐Bullous Lichen Planus Pemphigoides With Dupilumab,” Frontiers in Medicine 9 (2022): 1023458.
-
- T. E. Kim and M. K. Shin, “De Novo Case of Lichenoid Eruption Following Dupilumab Treatment,” JAAD Case Reports 13 (2021): 71–72.
-
- L. Kern, L. Kleinheinrich, R. Feldmann, P. Sator, A. Stella, and F. Breier, “Dupilumab‐Induced Lichen Planus: A Case With Oral and Cutaneous Eruptions,” Case Reports in Dermatology 14, no. 3 (2022): 356–361.
LinkOut - more resources
Full Text Sources